Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Reynolds

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
Psychological Medicine|November 1, 1988
Post-mortem neurochemistry of schizophreniaG P Reynolds
International Review of Neurobiology|January 1, 1995
Neurotransmitter systems in schizophreniaG P Reynolds
Molecular Psychiatry|November 1, 1996
Muscarinic M1 receptors in schizophreniaG P Reynolds
Lancet (London, England)|October 22, 1983
Serotonin receptors in suicide victimsG P Reynolds
Expert Opinion on Investigational Drugs|July 5, 2005
Developments in antipsychotic drugs - an updateG P Reynolds
The British Journal of Psychiatry : the Journal of Mental Science|January 18, 2006
Metabolic syndrome and schizophreniaG P Reynolds
Lancet (London, England)|October 15, 1988
Glutamate dehydrogenase activity in amyotrophic lateral sclerosisG P Reynolds
Journal of Psychopharmacology (Oxford, England)|January 1, 1997
5-HT receptors, genes and antipsychotic mechanismsG P Reynolds
Trends in Pharmacological Sciences|March 1, 1992
Developments in the drug treatment of schizophreniaG P Reynolds
Expert Opinion on Pharmacotherapy|May 5, 2001
Antipsychotic drug use in neurodegenerative disease in the elderly: problems and potential from a pharmacological perspectiveG P Reynolds
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
Psychological Medicine|November 1, 1988
Post-mortem neurochemistry of schizophreniaG P Reynolds
International Review of Neurobiology|January 1, 1995
Neurotransmitter systems in schizophreniaG P Reynolds
Molecular Psychiatry|November 1, 1996
Muscarinic M1 receptors in schizophreniaG P Reynolds
Lancet (London, England)|October 22, 1983
Serotonin receptors in suicide victimsG P Reynolds
Expert Opinion on Investigational Drugs|July 5, 2005
Developments in antipsychotic drugs - an updateG P Reynolds
The British Journal of Psychiatry : the Journal of Mental Science|January 18, 2006
Metabolic syndrome and schizophreniaG P Reynolds
Lancet (London, England)|October 15, 1988
Glutamate dehydrogenase activity in amyotrophic lateral sclerosisG P Reynolds
Journal of Psychopharmacology (Oxford, England)|January 1, 1997
5-HT receptors, genes and antipsychotic mechanismsG P Reynolds
Trends in Pharmacological Sciences|March 1, 1992
Developments in the drug treatment of schizophreniaG P Reynolds
Expert Opinion on Pharmacotherapy|May 5, 2001
Antipsychotic drug use in neurodegenerative disease in the elderly: problems and potential from a pharmacological perspectiveG P Reynolds
Pageof 19